Product Code: TMRGL26816
The report provides revenue of the global dermal fillers market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dermal fillers market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the dermal fillers market.
The report delves into the competitive landscape of the global dermal fillers market. Key players operating in the global dermal fillers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global dermal fillers market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dermal Fillers Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Dermal Fillers Market Analysis and Forecast, 2021-2031
5. Key Insights
- 5.1. Key Industry Developments
- 5.2. Dermal Fillers - Products Comparison
- 5.3. Dermal Filler Procedures
- 5.4. Regulatory Approval Process
- 5.5. Evolution of Dermal Fillers
- 5.6. Technological Advances
6. Global Dermal Fillers Market Analysis, by Product
- 6.1. Introduction
- 6.2. Global Dermal Fillers Market Value Share Analysis, by Product
- 6.3. Global Dermal Fillers Market Value Forecast, by Product, 2017-2031
- 6.3.1. Biodegradable
- 6.3.2. Non-biodegradable
- 6.4. Global Dermal Fillers Market Attractiveness Analysis, by Product
7. Global Dermal Fillers Market Analysis, by Material
- 7.1. Introduction
- 7.2. Global Dermal Fillers Market Value Share Analysis, by Material
- 7.3. Global Dermal Fillers Market Value Forecast, by Material, 2017-2031
- 7.3.1. Calcium Hydroxylapatite
- 7.3.2. Hyaluronic Acid
- 7.3.3. Collagen
- 7.3.4. Poly-L-Lactic Acid
- 7.3.5. PMMA
- 7.3.6. Fat
- 7.3.7. Others
- 7.4. Global Dermal Fillers Market Attractiveness Analysis, by Material
8. Global Dermal Fillers Market Analysis, by Application
- 8.1. Introduction
- 8.2. Global Dermal Fillers Market Value Share Analysis, by Application
- 8.3. Global Dermal Fillers Market Value Forecast, by Application, 2017-2031
- 8.3.1. Facial Line Correction Treatment
- 8.3.2. Lip Enhancement
- 8.3.3. Scar Treatment
- 8.3.4. Others
- 8.4. Global Dermal Fillers Market Attractiveness Analysis, by Application
9. Global Dermal Fillers Market Analysis, by End-user
- 9.1. Introduction
- 9.2. Global Dermal Fillers Market Value Share Analysis, by End-user
- 9.3. Global Dermal Fillers Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Dermatology Clinics
- 9.3.4. Others
- 9.4. Global Dermal Fillers Market Attractiveness Analysis, by End-user
10. Global Dermal Fillers Market Analysis, by Region
- 10.1. Introduction
- 10.2. Global Dermal Fillers Market Value Share Analysis, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Global Dermal Fillers Market Attractiveness Analysis, by Region
11. North America Dermal Fillers Market Analysis
- 11.1. Key Findings
- 11.2. North America Dermal Fillers Market Value Forecast, by Country, 2017-2031
- 11.2.1. U.S.
- 11.2.2. Canada
- 11.3. North America Dermal Fillers Market Value Forecast, by Product, 2017-2031
- 11.3.1. Biodegradable
- 11.3.2. Non-biodegradable
- 11.4. North America Dermal Fillers Market Value Forecast, by Material, 2017-2031
- 11.4.1. Calcium Hydroxylapatite
- 11.4.2. Hyaluronic Acid
- 11.4.3. Collagen
- 11.4.4. Poly-L-Lactic Acid
- 11.4.5. PMMA
- 11.4.6. Fat
- 11.4.7. Others
- 11.5. North America Dermal Fillers Market Value Forecast, by Application, 2017-2031
- 11.5.1. Facial Line Correction Treatment
- 11.5.2. Lip Enhancement
- 11.5.3. Scar Treatment
- 11.5.4. Others
- 11.6. North America Dermal Fillers Market Value Forecast, by End-user, 2017-2031
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Surgical Centers
- 11.6.3. Dermatology Clinics
- 11.6.4. Others
- 11.7. North America Market Attractiveness Analysis
- 11.7.1. By Country
- 11.7.2. By Product
- 11.7.3. By Material
- 11.7.4. By Application
- 11.7.5. By End-user
12. Europe Dermal Fillers Market Analysis
- 12.1. Key Findings
- 12.2. Europe Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.2.1. U.K.
- 12.2.2. Germany
- 12.2.3. France
- 12.2.4. Italy
- 12.2.5. Spain
- 12.2.6. Rest of Europe
- 12.3. Europe Dermal Fillers Market Value Forecast, by Product, 2017-2031
- 12.3.1. Biodegradable
- 12.3.2. Non-biodegradable
- 12.4. Europe Dermal Fillers Market Value Forecast, by Material, 2017-2031
- 12.4.1. Calcium Hydroxylapatite
- 12.4.2. Hyaluronic Acid
- 12.4.3. Collagen
- 12.4.4. Poly-L-Lactic Acid
- 12.4.5. PMMA
- 12.4.6. Fat
- 12.4.7. Others
- 12.5. Europe Dermal Fillers Market Value Forecast, by Application, 2017-2031
- 12.5.1. Facial Line Correction Treatment
- 12.5.2. Lip Enhancement
- 12.5.3. Scar Treatment
- 12.5.4. Others
- 12.6. Europe Dermal Fillers Market Value Forecast, by End-user, 2017-2031
- 12.6.1. Hospitals
- 12.6.2. Ambulatory Surgical Centers
- 12.6.3. Dermatology Clinics
- 12.6.4. Others
- 12.7. Europe Market Attractiveness Analysis
- 12.7.1. By Country/Sub-region
- 12.7.2. By Product
- 12.7.3. By Material
- 12.7.4. By Application
- 12.7.5. By End-user
13. Asia Pacific Dermal Fillers Market Analysis
- 13.1. Key Findings
- 13.2. Asia Pacific Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.2.1. China
- 13.2.2. Japan
- 13.2.3. India
- 13.2.4. Australia
- 13.2.5. Rest of Asia Pacific
- 13.3. Asia Pacific Dermal Fillers Market Value Forecast, by Product, 2017-2031
- 13.3.1. Biodegradable
- 13.3.2. Non-biodegradable
- 13.4. Asia Pacific Dermal Fillers Market Value Forecast, by Material, 2017-2031
- 13.4.1. Calcium Hydroxylapatite
- 13.4.2. Hyaluronic Acid
- 13.4.3. Collagen
- 13.4.4. Poly-L-Lactic Acid
- 13.4.5. PMMA
- 13.4.6. Fat
- 13.4.7. Others
- 13.5. Asia Pacific Dermal Fillers Market Value Forecast, by Application, 2017-2031
- 13.5.1. Facial Line Correction Treatment
- 13.5.2. Lip Enhancement
- 13.5.3. Scar Treatment
- 13.5.4. Others
- 13.6. Asia Pacific Dermal Fillers Market Value Forecast, by End-user, 2021-2031
- 13.6.1. Hospitals
- 13.6.2. Ambulatory Surgical Centers
- 13.6.3. Dermatology Clinics
- 13.6.4. Others
- 13.7. Asia Pacific Market Attractiveness Analysis
- 13.7.1. By Country/Sub-region
- 13.7.2. By Product
- 13.7.3. By Material
- 13.7.4. By Application
- 13.7.5. By End-user
14. Latin America Dermal Fillers Market Analysis
- 14.1. Key Findings
- 14.2. Latin America Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.2.1. Brazil
- 14.2.2. Mexico
- 14.2.3. Rest of Latin America
- 14.3. Latin America Dermal Fillers Market Value Forecast, by Product, 2017-2031
- 14.3.1. Biodegradable
- 14.3.2. Non-biodegradable
- 14.4. Latin America Dermal Fillers Market Value Forecast, by Material, 2017-2031
- 14.4.1. Calcium Hydroxylapatite
- 14.4.2. Hyaluronic Acid
- 14.4.3. Collagen
- 14.4.4. Poly-L-Lactic Acid
- 14.4.5. PMMA
- 14.4.6. Fat
- 14.4.7. Others
- 14.5. Latin America Dermal Fillers Market Value Forecast, by Application, 2017-2031
- 14.5.1. Facial Line Correction Treatment
- 14.5.2. Lip Enhancement
- 14.5.3. Scar Treatment
- 14.5.4. Others
- 14.6. Latin America Dermal Fillers Market Value Forecast, by End-user, 2017-2031
- 14.6.1. Hospitals
- 14.6.2. Ambulatory Surgical Centers
- 14.6.3. Dermatology Clinics
- 14.6.4. Others
- 14.7. Latin America Market Attractiveness Analysis
- 14.7.1. By Country/Sub-region
- 14.7.2. By Product
- 14.7.3. By Material
- 14.7.4. By Application
- 14.7.5. By End-user
15. Middle East & Africa Dermal Fillers Market Analysis
- 15.1. Key Findings
- 15.2. Middle East & Africa Dermal Fillers Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.2.1. GCC Countries
- 15.2.2. South Africa
- 15.2.3. Rest of Middle East & Africa
- 15.3. Middle East & Africa Dermal Fillers Market Value Forecast, by Product, 2017-2031
- 15.3.1. Biodegradable
- 15.3.2. Non-biodegradable
- 15.4. Middle East & Africa Dermal Fillers Market Value Forecast, by Material, 2017-2031
- 15.4.1. Calcium Hydroxylapatite
- 15.4.2. Hyaluronic Acid
- 15.4.3. Collagen
- 15.4.4. Poly-L-Lactic Acid
- 15.4.5. PMMA
- 15.4.6. Fat
- 15.4.7. Others
- 15.5. Middle East & Africa Dermal Fillers Market Value Forecast, by Application, 2017-2031
- 15.5.1. Facial Line Correction Treatment
- 15.5.2. Lip Enhancement
- 15.5.3. Scar Treatment
- 15.5.4. Others
- 15.6. Middle East & Africa Dermal Fillers Market Value Forecast, by End-user, 2017-2031
- 15.6.1. Hospitals
- 15.6.2. Ambulatory Surgical Centers
- 15.6.3. Dermatology Clinics
- 15.6.4. Others
- 15.7. Middle East & Africa Market Attractiveness Analysis
- 15.7.1. By Country/Sub-region
- 15.7.2. By Product
- 15.7.3. By Material
- 15.7.4. By Application
- 15.7.5. By End-user
16. Competitive Landscape
- 16.1. Competition Matrix
- 16.2. Company Profiles
- 16.2.1. AbbVie Inc.
- 16.2.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.1.2. Financial Overview
- 16.2.1.3. Product Portfolio
- 16.2.1.4. SWOT Analysis
- 16.2.1.5. Strategic Overview
- 16.2.2. Sinclair
- 16.2.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.2.2. Product Portfolio
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Strategic Overview
- 16.2.3. Merz Pharma
- 16.2.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.3.2. Financial Overview
- 16.2.3.3. Product Portfolio
- 16.2.3.4. SWOT Analysis
- 16.2.3.5. Strategic Overview
- 16.2.4. GALDERMA
- 16.2.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.4.2. Financial Overview
- 16.2.4.3. Product Portfolio
- 16.2.4.4. SWOT Analysis
- 16.2.4.5. Strategic Overview
- 16.2.5. BioPlus Co., Ltd.
- 16.2.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.5.2. Product Portfolio
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Strategic Overview
- 16.2.6. Bioxis pharmaceuticals
- 16.2.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.6.2. Financial Overview
- 16.2.6.3. Product Portfolio
- 16.2.6.4. SWOT Analysis
- 16.2.7. SCULPT Luxury Dermal Fillers LTD
- 16.2.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.7.2. Product Portfolio
- 16.2.7.3. SWOT Analysis
- 16.2.8. DR. Korman
- 16.2.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.8.2. Financial Overview
- 16.2.8.3. Product Portfolio
- 16.2.8.4. SWOT Analysis
- 16.2.9. Prollenium Medical Technologies
- 16.2.9.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.9.2. Product Portfolio
- 16.2.9.3. SWOT Analysis
- 16.2.10. Advanced Aesthetic Technologies, Inc.
- 16.2.10.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.10.2. Financial Overview
- 16.2.10.3. Product Portfolio
- 16.2.10.4. SWOT Analysis
- 16.2.11. TEOXANE Laboratories
- 16.2.11.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 16.2.11.2. Financial Overview
- 16.2.11.3. Product Portfolio
- 16.2.11.4. SWOT Analysis